Truqap is often a kinase inhibitor that actually works by blocking pathways that enable the most cancers cells endure and grow, so minimizes cancer growth. Truqap is from a category of medicines identified as an AKT inhibitor. Truqap gained FDA acceptance on November 17, 2023, following good final results from https://louisz237coy0.wikihearsay.com/user